Hippo Holdings Inc. (NYSE: HIPO) and Accelerant (NYSE: ARX) announced an enhanced partnership on June 30, 2026, structured to expand access to the specialty insurance market. The deal directly updated Hippo's forward guidance: the San Jose-based company now expects to reach $2 billion in gross written premium by 2027, a full year ahead of its prior plan of 2028.
Revised GWP Timeline
The guidance change moves Hippo's $2 billion GWP milestone forward by 12 months. The company attributed the acceleration explicitly to the Accelerant partnership — not to an organic shift in underwriting volume. GWP, the top-line premium measure before ceded reinsurance, is the most visible indicator of scale in an insurance operation. No loss ratio, expense ratio, or combined ratio figures accompanied the announcement.
Partnership Scope: Specialty Market Access
Accelerant, listed on the NYSE under ticker ARX and described in the announcement as a data-driven platform, is the mechanism Hippo is using to push deeper into the specialty insurance segment. Specialty lines cover non-standard risks that sit outside conventional underwriting parameters — a market that generally requires dedicated capacity and more granular data infrastructure than standard lines. The announcement does not specify which specialty lines are in scope, what premium volume Accelerant contributes directly, or how the arrangement affects Hippo's ceded-versus-retained premium structure.
What the Announcement Does Not Disclose
The press release excerpt provides no quarterly premium run rate, no product-line breakdown of the $2 billion target, and no geographic scope for the expanded arrangement. Accelerant's platform is characterized only as "data-driven" in the available summary; full commercial terms were not published. The single quantitative output of the announcement is the 2027 GWP target — one number, one year pulled forward, with the mechanics of how the partnership closes that gap left for subsequent disclosures.